Literature DB >> 17660700

Impaired glucose tolerance and impaired fasting glucose share similar underlying pathophysiologies.

Jiunn Diann Lin1, Hsiang-Lin Wan, Jer-Chuan Li, Chung-Ze Wu, Shi-Wen Kuo, Chang-Hsun Hsieh, Wei-Chen Lian, Chien-Hsing Lee, Mei-Teng Kao, Dee Pei.   

Abstract

Both impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) are pre-diabetic states. IGT was defined as having normal fasting plasma glucose (< 6.1 mmol/l) and abnormal 2-hr post-challenge plasma glucose. IFG was defined as having abnormal fasting plasma and normal 2-hr post-challenge plasma glucose (< 7.8 mmol/l). To explore whether these two abnormalities share similar underlying pathophysiologies, we evaluated risk factors of IGT and IFT using the models of factor analysis. The present study included 107 subjects with IGT and 52 with IFG. An oral glucose tolerance test and insulin suppression test, which could quantify insulin resistance, were performed on separate days. The risk factors include waist-to-hip ratio (WHR), triglycerides, high-density lipoprotein (HDL)-cholesterol, blood pressure, and fasting plasma glucose, which are associated with metabolic syndrome and insulin resistance. Factor analysis is a commonly used statistical method that could reduce a large number of risk factors into smaller numbers of groups, also called dimension. Accordingly, the complicated data could be interpreted more easily, since the related risk factors are grouped in one dimension. The results showed that the risk factors of IGT and IFG have similar grouping patterns. Triglyceride, insulin resistance, and HDL-cholesterol were grouped in one dimension (the lipid dimension), while WHR, mean blood pressure and fasting plasma glucose were grouped in another dimension (the metabolic dimension). In conclusion, except for WHR, the grouping patterns of the components in both IGT and IFG were nearly identical. These results suggest that IGT and IFG may share similar pathophysiologies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17660700     DOI: 10.1620/tjem.212.349

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  A mixture of Salacia oblonga extract and IP-PA1 reduces fasting plasma glucose (FPG) and low-density lipoprotein (LDL) cholesterol levels.

Authors:  Kazue Nakata; Yoshie Taniguchi; Noriko Yoshioka; Aya Yoshida; Hiroyuki Inagawa; Takeru Nakamoto; Hiroshi Yoshimura; Shin-Ichiro Miyake; Chie Kohchi; Masahide Kuroki; Gen-Ichiro Soma
Journal:  Nutr Res Pract       Date:  2011-10-28       Impact factor: 1.926

2.  Survey of Primary Care Physicians' Screening and Treatment Practices for Prediabetes in Saudi Arabia.

Authors:  Faisal Aljehani; Abdullah Alsulaiman; Abdulrahim Alqarni; Fahad Almutairi; May Samkari
Journal:  Cureus       Date:  2022-01-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.